Table 1.
Demographic data
| Gender (M/F) | 241/175 |
| Age (median (y), IQR) | 64.0 (15.4) |
| Height (median (cm), IQR) | 173.0 (15.8) |
| Weight (median (kg), IQR) | 87.8 (26.5) |
| BMI (median (kg/m2), IQR) | 29.4 (7.6) |
| Duration of diabetes (median (y), IQR) | 16.0 (16) |
| Type of diabetes (n (%)) | |
| Type 1 | 93 (22.4%) |
| Type 2 | 323 (77.6%) |
| Drugs (n (%)) | |
| Lipid lowering drugs | 267 (64.2%) |
| Oral blood glucose lowering drugs | 229 (55.0%) |
| Insulin | 351 (84.4%) |
| HbA1c (median (mmol/L), IQR) | 60.0 (17.0) |
| MDRD (median ml/min/1.73 m, IQR) | 77.9 (36.0) |
| Total cholesterol (median (mmol/L), IQR) | 4.0 (1.3) |
| LDL‐C (median (mmol/L), IQR) | 1.8 (1.1) |
| HDL‐C (median (mmol/L), IQR) | 1.3 (0.5) |
| TG (median (median mmol/L), IQR) | 1.6 (1.4) |
| Systolic blood pressure (median mmHg, IQR) | 136.0 (23) |
| Diastolic blood pressure (median mmHg, IQR) | 77.0 (13) |
| Diabetic sensory polyneuropathy (n (%) | |
| MNSI score ≥ 4 | 148 (35.6%) |
| Retinopathy (n (%)) | 59 (14.2%) |
BMI, body mass index; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; IQR, interquartile range; LDL, low density lipoprotein; MDRD, Modification of Diet in Renal Disease; M/F, male/female; TG, triglycerides.